Official registry condition

Menopause peptide trials

5 selected ClinicalTrials.gov records carrying the official condition label Menopause. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

5 selected records.

Connected peptides

4 profiles.

Registry update years

2018–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases5

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 184 selected PubMed records and 45 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Menopause unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00608062

PeptideScanner retained ClinicalTrials.gov record NCT00608062 at 2026-11-15T22:03:26.540Z. Its registry update date was 2020-12-24, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 24, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02042196

PeptideScanner retained ClinicalTrials.gov record NCT02042196 at 2026-11-15T22:02:39.332Z. Its registry update date was 2019-07-11, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 11, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06715514

PeptideScanner retained ClinicalTrials.gov record NCT06715514 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was semaglutide.

PeptideScanner change date
November 14, 2026
Cited source date
October 16, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →